ISCIII

Health Institute Carlos III

Information
Avenida Monforte de Lemos, 5. 28029, Madrid.

pollution, covid-19, rare diseases, epidemiology, immunology, microbiology, AIDS / HIV
Contact
José A. Plaza
Head of Communications
ja.plaza@isciii.es
918227196 / 669187384

If you are the contact person for this centre and you wish to make any changes, please contact us.

SMC participants

Director of the National Centre for Tropical Medicine (CNMT) at the Carlos III Health Institute

PhD in Pharmacy, Professor of Human Physiology at the University of Navarra, member of the CIBER Physiopathology of Obesity, Carlos III Health Institute and IDISNA (Navarra)

Head of the Influenza and other Respiratory Virus Surveillance Group of the National Epidemiology Centre.

Researcher at the Reference and Research Laboratory in Mycology, National Microbiology Centre, Instituto de Salud Carlos III

Senior Scientist at the Health Institute Carlos III

HIV, STI and hepatitis B and C Surveillance Unit. National Centre of Epidemiology, Health Institute Carlos III

Researcher in social epidemiology, public health and biostatistics 

Researcher with a PhD employed at the National Epidemiology Centre of the Carlos III Health Institute (ISCIII)

Research scientist and member of the Department of Climate Change, Health and the Urban Environment at the Carlos III Health Institute

Senior Scientist at the Special Pathogens Research and Reference Laboratory of the National Microbiology Centre of the Carlos III Health Institute

Director and Research Scientist at the Institute for Rare Diseases Research (IIER), Carlos III Health Institute (ISCIII)

 

Researcher at the National Center for Microbiology - Carlos III Health Institute

Senior scientist at the Reference Laboratory for Influenza and Respiratory Viruses of the National Microbiology Centre.

Scientific researcher at the National Epidemiology Centre - Carlos III Institute of Health

 

Head of the Respiratory Virus and Influenza Research Group of the Carlos III Health Institute

Full professor of Pathological Anatomy at the University of Oviedo, Scientific Director of the Principality of Asturias Biobank (BioPA) and Coordinator of the Organoid hub of the ISCIII Biomodels and Biobanks platform

Senior Scientist, Immunology Laboratory, Carlos III Health Institute

Research Professor at IDIBAPS-Hospital Clínic de Barcelona and Scientific Director of CIBEREHD - Carlos III Health Institute

Researcher in Vaccine-Preventable Disease Epidemiology at the National Centre of Epidemiology of the Health Institute Carlos III and member of CIBERESP

Scientific researcher at the Reference and Research Laboratory for Immunopreventable Viral Diseases of the National Microbiology Centre - Carlos III Health Institute

Research professor and member of the Departament on Climate Change, Health and the Urban Environment at the Carlos III Health Institute

Senior Researcher, Head of the Enterovirus and Viral Gastroenteritis Unit (Reference and Research Laboratory for Immunopreventable Viral Diseases), Centro Nacional de Microbiología, Instituto de Salud Carlos III

Head of the Central Scientific-Technical Units and Head of the Veterinary Unit of the Carlos III Health Institute

Head of the National Reference Laboratory for Gastroenteritis-Producing Viruses of the National Microbiology Centre - Carlos III Health Institute

Postdoctoral researcher at the Instituto de Investigaciones Raras Health Institute Carlos III

Virologist at the Reference Laboratory for Influenza and Respiratory Viruses of the National Microbiology Centre - Carlos III Health Institute

Cancer epidemiologist and Director General of the Carlos III Health Institute

Researcher at the National Epidemiology Centre of the Carlos III Health Institute, Associate Professor of Preventive Medicine and Public Health at the University of Alcalá.

Researcher at the National Epidemiology Centre (CNE-ISCIII)

Scientific researcher at the Cancer and Environmental Epidemiology Unit of the National Epidemiology Centre, Carlos III Health Institute, member of CIBERESP and co-coordinator of the Cancer Epidemiological Surveillance Sub-programme - VICA of CIBERESP

Senior Researcher at the Carlos III Health Institute, Head of the Neuro-oncology Unit at the Chronic Diseases Research Unit (UFIEC-ISCIII)

ICREA Research Professor, Director of Andero Lab and the Rodent Behavioral Core at the Autonomous University of Barcelona (UAB), and researcher in the Department of Psychobiology and Methodology of Health Sciences at the UAB and at the Carlos III Health Institute, CIBERSAM

Assistant Professor in the Department of Preventive Medicine and Public Health at the University of Valencia, and researcher at the CIBER Centre for the Physiopathology of Obesity and Nutrition (CIBEROBN) at the Carlos III Institute

Researcher at the Reference Laboratory for Influenza and Respiratory Viruses at the Centro Nacional de Microbiología - Instituto de Salud Carlos III

Medical Epidemiologist at the National Epidemiology Centre - Carlos III Health Institute

Researcher in the Viral Biology laboratory of the Carlos III Health Institute

Senior Scientist at the Carlos III Health Institute, in the area of ​​Environmental Toxicology of the National Center for Environmental Health

HIV, STI and hepatitis B and C Surveillance Unit. National Centre of Epidemiology, Health Institute Carlos III

Contents related to this centre
Nobel Medicina

The Karolinska Institute has awarded the Nobel Prize in Medicine or Physiology to Karl Deisseroth, Peter Hegemann, and Georg Nagel for their discoveries regarding light-activated ion channels and optogenetics. This method, which makes it possible to activate or deactivate individual neurons in a living brain, “is currently used in laboratories around the world to unravel the mysteries of the brain,” the institute announced. 

Copernicus

The Atmosphere Watch analysis, published by the Copernicus Atmosphere Monitoring Service, shows how, in 2026, air pollution has crossed borders and caused nearly 40 per cent of the world’s population to be exposed to high levels of tropospheric ozone. This pollutant is produced when other harmful compounds react with sunlight and high temperatures. The report highlights the massive wildfires in France, Spain and Belgium this summer, which generated significant smoke transport, affecting air quality thousands of kilometres away. Furthermore, across Europe as a whole, successive heatwaves between June and August led to an increase in ozone emissions from local sources, resulting in the health protection limit values being exceeded.  

Brain

A team of Spanish researchers has investigated the early stages of metastatic cells taking hold in target organs and has discovered that there is a transitional stage during which these ‘metastatic seeds’ are particularly vulnerable. They have also demonstrated in mice and in human samples that these micrometastases can be eliminated using three drugs, two of which are already approved for other indications. The study is published in the journal Cancer Cell.

 

ultraprocessed

A pilot trial assessed the feasibility and acceptability of reducing the consumption of ultra-processed foods in the diets of patients with major depressive disorder. The study, which involved twenty participants from the United States, has been published in the journal JAMA Psychiatry and shows that scores for depression and anxiety were lower during the period of reduced consumption of ultra-processed foods than during the period of their usual diet. According to the authors, this is an exploratory study – in the form of a Research Letter – and, “at best, it generates hypotheses”.

Brain

A US-based team with Spanish participation has successfully transplanted cortical organoids—self-organizing fragments of lab-grown human brain tissue—into modified mice lacking most of their cerebral cortex, the brain layer responsible for functions ranging from cognition and language to attention and decision-making. The research, published in the journal Nature, shows that the human tissue survived, grew, and developed functional connections with the mice's brains and, extending beyond that, with the spinal cord. According to the authors, this could help generate new models for studying disease-related alterations in human brain circuits.

humo

A study led by the Carlos III Health Institute (ISCIII) shows that, between 2013 and 2018, on days when fires were recorded, there was an increase in A&E admissions for respiratory problems in nine Spanish provinces. At a briefing organised by SMC Spain, Cristina Linares and Julio Díaz, the study’s authors and researchers at the ISCIII, explained the implications of the research and called for a surveillance plan, alongside the monitoring of these harmful particles and compounds, in the face of increasingly severe wildfires.

lab mouse

A team from the United States exposed pregnant mice to a mild inflammatory agent so that their offspring would develop brain and behavioural changes similar to those seen in autism spectrum disorder. When these offspring reached adulthood, the researchers administered a dose of rapamycin — an immunosuppressant — and found that several of these changes improved for a few hours, including cerebral hyperactivity, the risk of seizures, sensory hypersensitivity, repetitive behaviours and abnormal organisation of the brain’s functional network. The authors, whose work is published in Nature Communications, emphasise in a press release that these effects are temporary and that repeated administration loses its efficacy. Furthermore, they point out that rapamycin’s high potential for toxicity and the fact that the study was conducted on mice rule out its widespread use in humans.

 

 

CRISPR Model

The range of CRISPR tools for genome editing can extend beyond nature-inspired designs thanks to proteins designed using artificial intelligence. A new study by Nobel laureate Jennifer Doudna’s team, published in Science, describes the design of synthetic RNA-guided nucleases, with sequences substantially different from those found in nature, which match or exceed the activity of their natural counterparts whilst offering novel properties.

old lady

A new study reveals that the proportion of adults with dementia has risen significantly in Mexico, Peru and Puerto Rico over the last two decades, rising from one in ten older adults to almost one in six; a trend that runs counter to that seen in the US and other wealthy countries. Rates remained stable in Cuba and the Dominican Republic. The authors urge investment in prevention, dementia screening and care infrastructure. The study is published in JAMA Neurology.

Gonorrhoea culture.

The latest reports from the European Centre for Disease Prevention and Control (ECDC) indicate a rise in bacterial sexually transmitted infections (STIs) across Europe. In 2024, notifications of gonorrhoea and syphilis, along with congenital syphilis, reached their highest levels in more than a decade, reflecting sustained transmission across multiple countries. Gonorrhoea has increased by more than 300 % over the past 10 years, with Spain among the countries with the highest rates, while syphilis has risen by around 100 %, with Spain also ranking second highest. Men who have sex with men are the most affected population group for both infections. Congenital syphilis increased by almost 250 %, described as “one of the most concerning findings” by two ECDC experts during the briefing presenting the results. Possible contributing factors include reduced condom use, an increase in sexual partners, as well as higher levels of testing.